The forces shaping markets and the economy are often hiding behind a blur of numbers.

So that's why we created The Big Take from Bloomberg Podcasts, to give you the context you need to make sense of it all.

Every day in just 15 minutes, we dive into one global business story that matters.

You'll hear from Bloomberg journalists like Matt Levine.

A lot of this meme stock stuff is, I think, embarrassing to the SEC.

Follow the Big Take podcast on the IHeart Radio app, Apple Podcasts, or wherever you listen.

It can be one of the worst days of someone's life to get a cancer diagnosis.

For a long time, patients at least knew chemotherapy was one path to being treated.

In some countries, that path has become a lot riskier.

That's because of the emergence of bacteria with the most extreme form of antibiotic resistance.

We are facing a difficult scenario to give chemotherapy and cure the cancer and get a drug risk infection and the patient dying of infections.

We don't know what to do. The world doesn't know what to do in the scenario.

That's the, if you're talking about the post-antibiotic era, you first see that in cancer patients.

I'm Jason Gale, a senior editor with Bloomberg News. On this new season of prognosis, we look at the

spread of infections around the world

that even our most potent antimicrobial medicines can't stop.

It's been described as a silent tsunami of catastrophic proportions

and it's happening faster than scientists previously thought.

The situation is getting worse, definitely getting worse,

because the drug resistance rate, the superbug rate, is increasing on a daily basis.

It's increasing.

So the number of patients dying are really high.

...